NSTEMI

基本解釋

Method: 70 ACS(STEMI, NSTEMI, UAP) patients and 20 SAPpatients were selected.
方法：選擇ACS患者70例，其中ST段擡高的急性心肌梗死(STEMI)患者32例，非ST段擡高的急性心肌梗死(NSTEMI)患者及不穩(wěn)定型心絞痛(UAP)患者分別爲(wèi)18、20例。
CONCLUSIONS: The CRUSADE bleeding score quantifies risk for in-hospital major bleeding across all postadmission treatments, which enhances baseline risk assessment for NSTEMI care.
結(jié)論:CRUSADE出血評(píng)分對(duì)所有入院後治療過程中的院內(nèi)嚴(yán)重出血風(fēng)險(xiǎn)進(jìn)行了定量分析，加強(qiáng)了NSTEMI治療的基線風(fēng)險(xiǎn)評(píng)估。